| Name | 2-(4-trifluoromethyl-phenyl)-thiazole-4-carboxylic acid ethyl ester |
|---|---|
| Synonyms |
Ethyl 2-[3-(trifluoromethyl)phenyl]-4-thiazolecboxylate
2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLE-4-CBOXYLIC ACID ETHYL ESTER 4-(Ethoxycbonyl)-2-[3-(trifluoromethyl)phenyl]-1,3-thiazole, 3-[4-(Ethoxycbonyl)-1,3-thiazol-2-yl]benzotrifluoride ETHYL 2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOLE-4-CBOXYLATE Ethyl 2-(3-(trifluoromethyl)phenyl)thiazole-4-cboxylate 4-Thiazolecboxylic acid, 2-[3-(trifluoromethyl)phenyl]-, ethyl ester 2-[4-(trifluoromethyl)phenyl]-4-thiazolecboxylic acid ethyl ester ethyl 2-(4-(trifluoroMethyl)phenyl)thiazol-4-cboxylate ETHYL 2-[4-(TRIFLUOROMETHYL)PHENYL]THIAZOLE-4-CBOXYLATE |
| Density | 1.337g/cm3 |
|---|---|
| Boiling Point | 365.2ºC at 760 mmHg |
| Molecular Formula | C13H10F3NO2S |
| Molecular Weight | 301.28400 |
| Flash Point | 174.7ºC |
| Exact Mass | 301.03800 |
| PSA | 67.43000 |
| LogP | 4.00560 |
| Vapour Pressure | 1.59E-05mmHg at 25°C |
| Index of Refraction | 1.521 |
| HS Code | 2934100090 |
|---|
|
~74%
132089-39-5 |
| Literature: Takeda Pharmaceutical Company Limited Patent: EP2264017 A1, 2010 ; Location in patent: Page/Page column 161-162 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |